Hilltop Holdings »

Abcellera Biologics shares owned by Hilltop Holdings

Quarter-by-quarter ownership of Abcellera Biologics (ABCL) shares owned by Hilltop Holdings from 13F filings

Historical chart of Hilltop Holdings investment in Abcellera Biologics

Tip: Access up to 7 years of quarterly data

All positions including Abcellera Biologics held by Hilltop Holdings consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Abcellera Biologics by Hilltop Holdings

Quarter filed Position value Share count Share price at filing
2026-06-30 $219k 28k 7.85

More positions owned by Hilltop Holdings

SPDR S&P 500 ETF Trust Tr Unit (SPY)
Apple (AAPL)
Caterpillar (CAT)
SPDR Gold Shares Gold Shs (GLD)
Invesco Qqq Tr Unit Ser 1 (QQQ)
NVIDIA Corporation (NVDA)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Amazon (AMZN)
iShares Iboxx Usd Iboxx Inv Cp Etf (LQD)
Alphabet Cap Stk Cl A (GOOGL)
iShares Russell 2000 ETF Russell 2000 Etf (IWM)
Microsoft Corporation (MSFT)
Alphabet Cap Stk Cl C (GOOG)
Micron Technology (MU)
Berkshire Hathaway Cl B New (BRK.B)

View all positions for Hilltop Holdings

Top funds holding Abcellera Biologics

Baker Bros. Advisors
Capital World Investors
Two Sigma Investments
TD Waterhouse Canada
Bank of America Corporation
Ubs Global Asset Management Americas
Arrowpoint Asset Management
BlackRock
Susquehanna International
Driehaus Capital Management
Citadel Advisors
Morgan Stanley
UBS Group
Tudor Investment Corporation
Marshall Wace

View all funds holding Abcellera Biologics